Skip Navigation

Cardiovascular Research 2004 61(3):448-460; doi:10.1016/j.cardiores.2003.09.024
© 2004 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Hausenloy, D. J
Right arrow Articles by Yellon, D. M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hausenloy, D. J
Right arrow Articles by Yellon, D. M
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2003, European Society of Cardiology

New directions for protecting the heart against ischaemia–reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway

Derek J Hausenloy and Derek M Yellon*

The Hatter Institute and Centre for Cardiology, University College London Hospital and Medical School, Grafton Way, London WC1E 6DB, UK

* Corresponding author. Tel.: +44-207-380-9776; fax: +44-207-388-5095. d.yellon{at}ucl.ac.uk, hatter-institute{at}ucl.ac.uk

Reperfusion is a pre-requisite to salvaging viable myocardium, following an acute myocardial infarction. Reperfusion of ischaemic myocardium, however, is not without risk, as the act of reperfusion itself can paradoxically result in myocyte death: a phenomenon termed lethal reperfusion-induced injury. Therapeutic strategies that target and attenuate reperfusion-induced cell death may provide novel pharmacological agents, which can be used as an adjunct to current reperfusion therapy, to limit myocardial infarction. Recent evidence has implicated apoptotic cell death during the phase of reperfusion as an important contributor to lethal reperfusion-induced injury. Targeting anti-apoptotic mechanisms of cellular protection at the time of reperfusion may therefore offer a potential approach to attenuating reperfusion-induced cell death. In this regard, ischaemia–reperfusion has been shown to activate the anti-apoptotic pro-survival kinase signalling cascades, phosphatidylinositol-3-OH kinase (PI3K)–Akt and p42/p44 extra-cellular signal-regulated kinases (Erk 1/2), both of which have been implicated in cellular survival. Activating these pro-survival kinase cascades at the time of reperfusion has been demonstrated to confer protection against reperfusion-induced injury. We and others have shown that insulin, insulin-like growth factor-1 (IGF-1), transforming growth factor-β1 (TGF-β1), cardiotrophin-1 (CT-1), urocortin, atorvastatin and bradykinin protect the heart, by activating the PI3K–Akt and/or Erk 1/2 kinase cascades, when given at the commencement of reperfusion, following a lethal ischaemic insult. Pharmacological manipulation and up-regulation of these pro-survival kinase cascades, which we refer to as the Reperfusion Injury Salvage Kinase (RISK) pathway, as an adjunct to reperfusion may therefore protect the myocardium from lethal reperfusion-induced cell death and provide a novel strategy to salvaging viable myocardium and limiting infarct size.

KEYWORDS Reperfusion injury; Protein kinases; Growth factors


Time for primary review 27 days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cardiovasc ResHome page
D. J. Hausenloy and D. M. Yellon
Cardioprotective growth factors
Cardiovasc Res, July 15, 2009; 83(2): 179 - 194.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Granfeldt, D. J. Lefer, and J. Vinten-Johansen
Protective ischaemia in patients: preconditioning and postconditioning
Cardiovasc Res, July 15, 2009; 83(2): 234 - 246.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
U. Hofmann, N. Burkard, C. Vogt, A. Thoma, S. Frantz, G. Ertl, O. Ritter, and A. Bonz
Protective effects of sphingosine-1-phosphate receptor agonist treatment after myocardial ischaemia-reperfusion
Cardiovasc Res, July 15, 2009; 83(2): 285 - 293.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
E. Gurel, K. M. Smeele, O. Eerbeek, A. Koeman, C. Demirci, M. W. Hollmann, and C. J. Zuurbier
Ischemic preconditioning affects hexokinase activity and HKII in different subcellular compartments throughout cardiac ischemia-reperfusion
J Appl Physiol, June 1, 2009; 106(6): 1909 - 1916.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
Y. Murozono, N. Takahashi, T. Shinohara, T. Ooie, Y. Teshima, M. Hara, T. Saikawa, and H. Yoshimatsu
Hyperthermia-Induced Cardioprotection Is Potentiated by Ischemic Postconditioning in Rats
Experimental Biology and Medicine, May 1, 2009; 234(5): 573 - 581.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Miyamoto, M. Rubio, and M. A. Sussman
Nuclear and mitochondrial signalling Akts in cardiomyocytes
Cardiovasc Res, May 1, 2009; 82(2): 272 - 285.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
U. Sen, N. Tyagi, P. K. Patibandla, W. L. Dean, S. C. Tyagi, A. M. Roberts, and D. Lominadze
Fibrinogen-induced endothelin-1 production from endothelial cells
Am J Physiol Cell Physiol, April 1, 2009; 296(4): C840 - C847.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
R. G. Katare, M. Ando, Y. Kakinuma, M. Arikawa, T. Handa, F. Yamasaki, and T. Sato
Vagal nerve stimulation prevents reperfusion injury through inhibition of opening of mitochondrial permeability transition pore independent of the bradycardiac effect.
J. Thorac. Cardiovasc. Surg., January 1, 2009; 137(1): 223 - 231.
[Abstract] [Full Text] [PDF]


Home page
Alcohol AlcoholHome page
K. Zhou, L. Zhang, J. Xi, W. Tian, and Z. Xu
Ethanol Prevents Oxidant-Induced Mitochondrial Permeability Transition Pore Opening in Cardiac Cells
Alcohol Alcohol., January 1, 2009; 44(1): 20 - 24.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. Ishii, T. Amano, T. Matsubara, and T. Murohara
Pharmacological Intervention for Prevention of Left Ventricular Remodeling and Improving Prognosis in Myocardial Infarction
Circulation, December 16, 2008; 118(25): 2710 - 2718.
[Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
K.-O. Stenslokken, S. Ellefsen, J. A. W. Stecyk, M. B. Dahl, G. E. Nilsson, and J. Vaage
Differential regulation of AMP-activated kinase and AKT kinase in response to oxygen availability in crucian carp (Carassius carassius)
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2008; 295(6): R1803 - R1814.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
O. Bouhidel, S. Pons, R. Souktani, R. Zini, A. Berdeaux, and B. Ghaleh
Myocardial ischemic postconditioning against ischemia-reperfusion is impaired in ob/ob mice
Am J Physiol Heart Circ Physiol, October 1, 2008; 295(4): H1580 - H1586.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
P. S. Pagel
Induction of Heat Shock Protein 70 and Preconditioning by Sevoflurane: A Potent Protective Interaction Against Myocardial Ischemia-Reperfusion Injury
Anesth. Analg., September 1, 2008; 107(3): 742 - 745.
[Full Text] [PDF]


Home page
Anesth. Analg.Home page
P. S. Pagel, J. G. Krolikowski, P. F. Pratt Jr, Y. H. Shim, J. Amour, D. C. Warltier, and D. Weihrauch
The Mechanism of Helium-Induced Preconditioning: A Direct Role for Nitric Oxide in Rabbits
Anesth. Analg., September 1, 2008; 107(3): 762 - 768.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
D. J. Hausenloy and D. M. Yellon
Time to Take Myocardial Reperfusion Injury Seriously
N. Engl. J. Med., July 31, 2008; 359(5): 518 - 520.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
L. Bertrand, S. Horman, C. Beauloye, and J.-L. Vanoverschelde
Insulin signalling in the heart
Cardiovasc Res, July 15, 2008; 79(2): 238 - 248.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Ye, J. D. Martinez, R. J. Perez-Polo, Y. Lin, B. F. Uretsky, and Y. Birnbaum
The role of eNOS, iNOS, and NF-{kappa}B in upregulation and activation of cyclooxygenase-2 and infarct size reduction by atorvastatin
Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H343 - H351.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
N. Suleman, S. Somers, R. Smith, L. H. Opie, and S. C. Lecour
Dual activation of STAT-3 and Akt is required during the trigger phase of ischaemic preconditioning
Cardiovasc Res, July 1, 2008; 79(1): 127 - 133.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
L. H. Opie
Metabolic Management of Acute Myocardial Infarction Comes to the Fore and Extends Beyond Control of Hyperglycemia
Circulation, April 29, 2008; 117(17): 2172 - 2177.
[Full Text] [PDF]


Home page
Physiol. Rev.Home page
E. Murphy and C. Steenbergen
Mechanisms Underlying Acute Protection From Cardiac Ischemia-Reperfusion Injury
Physiol Rev, April 1, 2008; 88(2): 581 - 609.
[Abstract] [Full Text] [PDF]


Home page
Nutr Clin PractHome page
J. M. Hollander and J. I. Mechanick
Nutrition Support and the Chronic Critical Illness Syndrome
Nutr Clin Pract, December 1, 2006; 21(6): 587 - 604.
[Abstract] [Full Text] [PDF]


Home page
JPEN J Parenter Enteral NutrHome page
J. I. Mechanick
Metabolic Mechanisms of Stress Hyperglycemia
JPEN J Parenter Enteral Nutr, March 1, 2006; 30(2): 157 - 163.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
D. A. Brown, A. J. Chicco, K. N. Jew, M. S. Johnson, J. M. Lynch, P. A. Watson, and R. L. Moore
Cardioprotection afforded by chronic exercise is mediated by the sarcolemmal, and not the mitochondrial, isoform of the KATP channel in the rat
J. Physiol., December 15, 2005; 569(3): 913 - 924.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.